Global Neurofibromatosis Type 1 market size is expected to reach $13.78 billion by 2030 at 9.2%, spontaneous (de novo) mutation driving the growth of the market
Read More
Global Neurofibromatosis Treatment market size is expected to reach $27.75 billion by 2030 at 13.5%, segmented as , surgical interventions, medication for symptom management, genetic counseling
Read More
The neurofeedback system market is projected to reach $2.61 billion by 2030, growing at 10.5% CAGR, driven by precision neurotherapy, AI-driven brain monitoring, and digital health integration.
Read More
The neurofeedback market is set to reach $2.6 billion by 2030, growing at 10.5% CAGR, driven by personalized mental health care, digital therapeutics, and AI-based brain training.
Read More
Global Neuroendocrine Tumor Treatment market size is expected to reach $3.98 billion by 2030 at 10.7%, rising neuroendocrine tumors fuel treatment market growth
Read More
Global Neuroendocrine Carcinoma market size is expected to reach $2.47 billion by 2030 at 7.1%, growth of targeted therapies driving the market expansion
Read More
Global Neurodiagnostics market size is expected to reach $13.48 billion by 2030 at 6.5%, rising prevalence of neurological disorders driving growth in the market
Read More
Optical Genome Mapping market size is expected to reach $0.74 billion by 2030 at 25.9%, segmented as by instruments, optical genome mapping systems, imaging systems, detection and analysis devices
Read More
Global Optic Neuropathy Management market size is expected to reach $5.07 billion by 2030 at 5.7%, growing prevalence of eye disease fuels the market
Read More
Optic Nerve Disorders Treatment market size is expected to reach $5.21 billion by 2030 at 5.7%, segmented as by steroidal therapy, corticosteroids, intravitreal steroid injections, oral steroids
Read More